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ess: jmmontserrat@ub.Summary Flow limitation during sleep occurs when the rise in esophageal pressure
is not accompanied by a flow increase which results in a non-rounded inspiratory flow
shape. Short periods of flow limitation ending in an arousal or in a fall in SaO2
(hypopnea or upper airway resistance syndrome) are detrimental but the role of
prolonged periods of flow limitation (PPFL) has not yet been clarified. This is
important not only for diagnosis but also for nasal continuous positive airway
pressure (CPAP) titration, especially for the automatic devices that need to be setup.
The aim of this study was to analyze the effects of PPFL. We compared the behavior
of the mean end-expiratory systemic blood pressure (SBP), end-tidal CO2,
esophageal pressure and the pattern of breathing during a period of normal
breathing at optimal (CPAP) and during PPFL at suboptimal CPAP in 14 patients with
sleep apnea/hypopnea syndrome during a full polysomnography CPAP titration. The
mean values of the parameters studied, at optimal and suboptimal CPAP were (1)
SBP 92713 vs. 91715mmHg (P: ns). At suboptimal CPAP, swings of blood pressure
were associated with changes in pleural pressure; (2) SaO2 97.571.2 vs. 96.571.6
(P: 0.03), (3) end-tidal CO2 43.574 vs. 49.574 (P : 0:001); (4) oesophageal pressure,
10.574 vs. 37.6715 cmH2O (P : 0:001) and (5) pattern of breathing: minute
ventilation 6.671.4 vs. 6.171.2 L/min (P: ns) and inspiratory time 1.2470.3 vs.
1.6670.4 s (P : 0:001). It can be concluded that PPFL induces significant physiolo-
gical changes. Nevertheless, given the scant literature, clinical studies are
warranted to elucidate the clinical role of these physiological changes.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Sleep apnea and hypopnea syndrome (SAHS) is a
common disorder that affects 2–4% of the adult
population.1 It is well known that in addition to
apneas or hypopneas,2 other respiratory events
such as the upper airway resistance syndrome
(UARS)3–5 take place during sleep.
Flow limitation occurs when increased esopha-
geal pressure is not accompanied by a flow
increase. Flow limitation depends on the interac-
tion between the negative pleural pressure, which
tends to collapse the upper airway, and upper
airway muscle activity, which helps to keep the
airway open. Flow limitation represents the phy-
siological basis of the UARS also known as respira-
tory effort-related arousal (RERA). Its main
characteristic is a flattening of the inspiratory flow
shape which can be measured noninvasively by
nasal prongs at diagnosis or by a pneumotachograph
during continuous positive airway pressure (CPAP)
titration.
Although short periods of flow limitation (UARS or
RERA) are accepted as disturbed breathing events.4
The physiological and clinical role of prolonged
periods of flow limitation (PPFL) has not been
completely clarified.6 These events could play a role
in the symptoms of some patients, for instance in
those that show a lack of improvement when under-
going CPAP and in whom PPFL are not eliminated
during titration. This could also exert an influence on
the setup of the automatic CPAP devices.
Although most CPAP titration clinical protocols
recommend the elimination of apneas, hypopneas
and snoring,7 there is no agreement on the need to
correct PPFL. There are very few data that suggest
that flow limitation should be eliminated during
CPAP titration.8 However, the fact that PPFL can
occur in healthy snoring subjects, e.g. in delta
sleep, gives rise to some reservations concerning
the need to correct PPFL during sleep. Given the
inconclusive results of earlier studies, we made a
reappraisal of the subject by analyzing, as a first
step, the behavior of physiological parameters such
as ventilation, blood pressure, pattern of breathing
and end-tidal CO2. To this end, we induced PPFL by
suboptimal CPAP during a full polysomnography
(PSG) CPAP titration and compared to data with the
results from periods of optimal CPAP.Materials and methods
Fourteen male patients diagnosed with SAHS and
requiring CPAP treatment9 were recruited. The
mean data from these patients were: age: 5278(SD)years; body mass index: 3376 kg/m2; apnea–
hypopnea index: 5978 events/h; CT90: 41723;
and Epworth sleepiness scale: 1675. The Ethics
Committee of the Hospital approved the protocol
and all the patients gave their informed written
consent.
The measurements were made during a CPAP
titration after training the patients in the use of
nasal CPAP. Titration was performed during full PSG
in the usual manner by measuring neurological and
respiratory variables.10–12 Apnea was defined as an
absence of airflow ofX10 s, and a hypopnea as any
discernible airflow reduction for at least 10 s, with
a drop in oxygen saturation X3% or final arou-
sal.10,11 A pneumotachograph located between the
leak valve and the mask allowed us to assess the
different respiratory events and to compute minute
ventilation, inspiratory time and breathing rate.
Figure 1 shows different flow signal contours
defining flow limitation. In addition, the following
parameters were measured: (1) systemic blood
pressure (SBP) by finger photoplethysmography
(Finapress, Ohmeda, Englewood, CO), (2) end-tidal
CO2 using TONOCAP 808289, Datex-Enstrom, Ins.
Corp., Helsinki, sampled from the nose by a special
device (878467-1, Datex-Engstrom, Helsinki, and
(3) esophageal pressure.
The study, carried out in sleep phase 2 or delta
sleep, was initiated at CPAP ¼ 4 cm H2O and nasal
pressure was increased by 1 cmH2O in response to
repetitive events (apneas, hypopneas and flow
limitation periods) until an optimal pressure was
obtained. This was defined as the absence of
repetitive events, a clearly rounded inspiratory
flow shape and achievement of normal neurological
sleep parameters. This optimal CPAP pressure was
maintained for a prolonged period of time (20min)
and then a gradual pressure reduction was applied
to obtain PPFL lasting more than 10min (subopti-
mal CPAP). End-expiratory SBP, SaO2, end-tidal
CO2, esophageal pressure and breathing pattern
parameters were measured during the period of
normal breathing and during PPFL. The variables
measured during optimal and suboptimal CPAPs
were compared using a paired t-test or Mann–
Whitney test depending on normality. A level of
Po0:05 was used for statistical significance.Results
As the CPAP pressure level was increased over the
course of the study, the apneas usually became
hypopneas followed by PPFL and normal breathing.
Figure 2 shows three different levels of CPAP in a
representative patient. At 4 cmH2O, apneas can be
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Figure 1 Examples of characteristic breathing patterns showing inspiratory flow limitation. All three inspiratory
contours are flow limited, as indicated by the lack of roundness during inspiration. Flow limitation is due to upper
airway collapse resulting from unbalance between high negative esophageal pressure and low upper airway muscle
activity. In this figure inspiration corresponds to upwards flow.
Figure 2 Three different levels of CPAP in a representative patient: (1) at the start (4 cmH2O), apneas were present; (2)
at optimal CPAP, breathing was normal and (3) at suboptimal CPAP, there was a period of flow limitation. In this step the
end-tidal CO2 increased, large esophageal pressure swings were observed and the systemic blood pressure showed a
fluctuation.
Physiological consequences of PPFL 815seen with large esophageal pressure swings and
observable oscillations of blood pressure. At opti-
mal CPAP, normal values of the different para-
meters were observed. The inspiratory flow shapes
were rounded, with normal values of esophageal
pressure. PPFL was found at suboptimal CPAP.
The inspiratory flow shapes were clearly limited.
The end-tidal CO2 increased, large esophagealpressure swings were observed and the SBP showed
fluctuations.
Table 1 shows the main results. Mean end-
expiratory SBP did not show a statistically signifi-
cant change between optimal CPAP and suboptimal
CPAP (PPFL). By contrast, SaO2 during PPFL
decreased with respect to optimal CPAP, probably
due to hypoventilation. End-tidal CO2 increased
ARTICLE IN PRESS
Table 1 Mean end-expiratory systemic blood pressure, end-tidal CO2, SaO2, esophageal pressure, minute
ventilation and inspiratory time during optimal CPAP and during the prolonged periods of flow limitation at sub-
optimal CPAP.
Parameters Optimal CPAP (Sub-Optimal CPAP) (p)
Systemic blood pressure (mm Hg) 92713 91715 n.s.
SaO2 (%) 97.571.2 96.571.6 0.03
End-tidal CO2 (mm Hg) 43.574 49.574 0.001
Esophageal pressure (cmH2O) 10.574 37.6715 0.001
Minute ventilation (l/s) 6.671.4 6.171.2 n.s
Inspiratory time (s) 1.2470.3 1.6670.4 0.001
G. Calero et al.816significantly during PPFL with respect to the values
during optimal CPAP. As expected, the values of
esophageal pressure swings were significantly high-
er during PPFL than during optimal CPAP. As
regards, the breathing pattern, minute ventilation
decreased approximately by 10% during PPFL
compared with the minute ventilation during
optimal CPAP, although not significantly. The
decrease in minute ventilation was accompanied
by a significant increase in the inspiratory time
during the PPFL with respect to the inspiratory time
during optimal CPAP.Discussion
Our understanding of sleep apnea has evolved over
time. Early research focused on pure obstructive
sleep apnea i.e. total upper airway obstruction.
This disorder corresponds to a static upper airway
occlusion due to critical pressure being lower than
atmospheric pressure. Subsequently, the concepts
of hypopnea,2 UARS3 and short periods of flow
limitation without a drop in SaO2 or arousal have
been shown to play a role in SAHS.8 All these three
events have the same pathophysiological basis: the
upper airway closes partially during inspiration
because of negative pleural pressure and low upper
airway muscle activity. The result is a limitation of
the inspiratory flow shape contour (Fig. 1). This
phenomenon is also known as upper airway dynamic
obstruction since the critical pressure is similar to
atmospheric pressure.13
During CPAP titration, at suboptimal CPAP, PPFL
occurs in association with negative swings of
esophageal pressure.5 Our study concerns the need
to correct such PPFL. We have demonstrated that
these periods have some adverse physiological
consequences. Given the high pleural pressure
swings occurring in these periods, it is conceivable
that a hemodynamic workload is produced14,15along with brief disruptions in cortical activity that
could contribute to some clinical symptoms.16 The
description of the role of negative esophageal
pressure swings in the genesis of systemic hyper-
tension has also focused attention on cardiovascu-
lar consequences induced by PPFL.17–20 The role of
the respiratory efforts has recently been shown to
induce an immune response.21 Finally, it has been
demonstrated that correcting flow limitation and
snoring in preeclamsia normalizes SBP.19 It there-
fore seems that PPFL could have some harmful
effects.
As far as clinical practice is concerned, there is
little literature on this topic. The vigilance and
cognitive test improvement in patients with cor-
rected and uncorrected flow limitation were
studied.8 This report showed that the correction
of flow limitation together with the elimination of
apnea, hypopnea and snoring with CPAP did not
enhance sleep quality. The analysis of the changes
in the maintenance of wakefulness time demon-
strated a significantly greater scattering of final
values when flow limitation was not corrected by
nasal CPAP. This suggests an improvement in
objective daytime performance. The authors con-
cluded that flow limitation should be detected and
corrected.
In the light of our findings, and of other authors,
it should be pointed out that the usual criterion for
considering an optimal CPAP—suppression of ap-
nea/hypopnea and snoring—may not be the most
suitable approach. We suggest that high pleural
pressure swings occurring in PPFL should be
considered and normalized by achieving a rounded
flow contour shape. This is important not just in
diagnostic studies but also in the CPAP titration
procedures whether manual or involving automatic
devices where the settings need to be set-up. It
goes without saying that further clinical studies are
needed to provide more insight into the role of the
physiological changes and clinical consequences
induced by PPFL.
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